Lung cancer prediction using robust machine learning and image enhancement methods | CellTalk

In the present era, cancer is the leading cause of demise in both men and women worldwide, with low survival rates due to inefficient diagnostic techniques. In the year 2021, about 1,898,160 new cancer cases were encountered, 608,570 deaths were projected in the United States, and 85% were non-small cell lung cancer (NSCLC), among others. NSCLC can be detected with radiofrequency (RF) excision and stereotactic body radiotherapy (SBRT) methods.

Lung cancer has two main types, i.e., NSCLC and small cell lung carcinoma (SCLC). Both of these types of cancer spread in different ways and require different treatments accordingly. NSCLC spreads very slowly and is different than SCLC, which is related to smoking, and propagates very rapidly, forms tumors, and spreads to different parts of the body. The deaths based on SCLC are proportional to the number of cigarettes smoked.

Read more  (https://www.celltalk.org/jay-darji-pr...)

#LungCancer #NonSmallCellLungCancer #Chemotherapy #AdjuvantChemotherapy #Radiofrequency #StereotacticBodyRadiotherapy #NeoadjuvantChemotherapy #Nivolumab #Radiotherapy #CellTalk #LifeScinces #Journal #HealthJournal #JournalClub #Healthcare #YouTube #SocialMedia

For more interesting videos
---------------------------------------------
Subscribe to CellTalk: @celltalk8633
You may also like to watch: Neoadjuvant Nivolumab plus chemothera...

Connect with us on social:
---------------------------------------------
LinkedIn: LinkedIn: celltalk
Facebook: Facebook: Celltalk-101057335993489
Visit CellTalk: https://www.celltalk.org/